258 related articles for article (PubMed ID: 33141069)
1. Bisphosphonates in veterinary medicine: The new horizon for use.
Suva LJ; Cooper A; Watts AE; Ebetino FH; Price J; Gaddy D
Bone; 2021 Jan; 142():115711. PubMed ID: 33141069
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate use in the horse: what is good and what is not?
Mitchell A; Watts AE; Ebetino FH; Suva LJ
BMC Vet Res; 2019 Jun; 15(1):211. PubMed ID: 31234844
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates: the first 40 years.
Russell RG
Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
Russell RG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH
Ann N Y Acad Sci; 2007 Nov; 1117():209-57. PubMed ID: 18056045
[TBL] [Abstract][Full Text] [Related]
6. The backbone of progress--preclinical studies and innovations with zoledronic acid.
Green JR; Guenther A
Crit Rev Oncol Hematol; 2011 Feb; 77 Suppl 1():S3-S12. PubMed ID: 21353178
[TBL] [Abstract][Full Text] [Related]
7. The critical role of bisphosphonates to target bone cancer metastasis: an overview.
Singh T; Kaur V; Kumar M; Kaur P; Murthy RS; Rawal RK
J Drug Target; 2015 Jan; 23(1):1-15. PubMed ID: 25203856
[TBL] [Abstract][Full Text] [Related]
8. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of Metastatic Bone Disease and the Role of the Second Generation of Bisphosphonates: From Basic Science to Medicine.
Barghash RF; Abdou WM
Curr Pharm Des; 2016; 22(11):1546-57. PubMed ID: 26795564
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of bisphosphonates.
Rodan GA
Annu Rev Pharmacol Toxicol; 1998; 38():375-88. PubMed ID: 9597160
[TBL] [Abstract][Full Text] [Related]
11. [Development of bisphosphonates].
Nakatsuka K
Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates and cancer.
Milner RJ; Farese J; Henry CJ; Selting K; Fan TM; de Lorimier LP
J Vet Intern Med; 2004; 18(5):597-604. PubMed ID: 15515572
[TBL] [Abstract][Full Text] [Related]
13. New role for an established drug? Bisphosphonates as potential anticancer agents.
Koul HK; Koul S; Meacham RB
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):111-9. PubMed ID: 21876554
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates in oncology.
Coleman RE; McCloskey EV
Bone; 2011 Jul; 49(1):71-6. PubMed ID: 21320652
[TBL] [Abstract][Full Text] [Related]
15. Nitrogen-containing bisphosphonate mechanism of action.
Reszka AA; Rodan GA
Mini Rev Med Chem; 2004 Sep; 4(7):711-9. PubMed ID: 15379639
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates: new therapeutic agents for the treatment of bone tumors.
Heymann D; Ory B; Gouin F; Green JR; Rédini F
Trends Mol Med; 2004 Jul; 10(7):337-43. PubMed ID: 15242682
[TBL] [Abstract][Full Text] [Related]
17. On the pharmacological evaluation of bisphosphonates in humans.
Cremers S; Ebetino FH; Phipps R
Bone; 2020 Oct; 139():115501. PubMed ID: 32599224
[TBL] [Abstract][Full Text] [Related]
18. Use of bisphosphonates in patients with metastatic bone disease.
Berenson JR; Lipton A
Oncology (Williston Park); 1998 Nov; 12(11):1573-9; discussion 1579-81. PubMed ID: 9834935
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.
Li J; Rugo HS
Breast Dis; 2011; 33(2):83-92. PubMed ID: 22142661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
